InsiderClue
Insiders · Profile

Wahlstrom Mats

Director at TriSalus Life Sciences · Director at Coherus Oncology. Filing since 14 Aug 2015. CIK 0001459154

TLSI TriSalus Life Sciences, Inc. Director · 4 trades CHRS Coherus Oncology, Inc. Director · 8 trades
Company
Date
Role
Action
Shares
Amount
Of holding
TLSI TriSalus Life Sciences, Inc.
15 May 2026
Director
Bought
60,000
$151.80K
68.5%
CHRS Coherus Oncology, Inc.
23 May 2025
Director
Sold at will
99,988
$73.88K
100%
TLSI TriSalus Life Sciences, Inc.
22 Nov 2024
Director
Bought
5,000
$22.75K
46.6%
TLSI TriSalus Life Sciences, Inc.
21 Nov 2024
Director
Bought
8,687
$38.57K
426%
TLSI TriSalus Life Sciences, Inc.
20 Nov 2024
Director
Bought
2,040
$8.49K
opened
CHRS Coherus Oncology, Inc.
17 Jun 2020
Director
Sold, plan not stated
200,000
$3.43M
100%
CHRS Coherus Oncology, Inc.
3 Mar 2020
Director
Sold, plan not stated
118,066
$2.38M
37.1%
CHRS Coherus Oncology, Inc.
8 Dec 2016
Director
Sold, plan not stated
46,190
$1.27M
100%
CHRS Coherus Oncology, Inc.
7 Dec 2016
Director
Sold, plan not stated
7,393
$203.33K
13.8%
CHRS Coherus Oncology, Inc.
18 Aug 2015
Director
Sold, plan not stated
6,373
$213.51K
1.1%
CHRS Coherus Oncology, Inc.
17 Aug 2015
Director
Sold, plan not stated
8,028
$272.22K
1.4%
CHRS Coherus Oncology, Inc.
14 Aug 2015
Director
Sold, plan not stated
116,554
$3.99M
16.4%
12 decisions on file.